Inside Innovation

Seattle was recently named the top U.S. city for LGBTQ+ employees, beating out Chicago, Washington D.C., San Francisco and New York to take the number

Congratulations are in order for sponsor company Adaptive Biotechnologies, which made Puget Sound Business Journal’s list of 2021 Best Workplaces in Washington. The annual award

Nautilus Biotechnology recently raised $345 million via SPAC to fuel a new approach that could accelerate biomedical research and transform drug development. Propelled by this

Seattle-based law firm Perkins Coie is launching The Black Boardroom Initiative, which aims to grow the diversity of S&P 500 corporate boards by increasing the

An ultrapotent, second-generation COVID-19 vaccine candidate developed by the University of Washington Medicine’s Institute for Protein Design and South Korea-based SK bioscience received $173.4 million

Spokane-based Jubilant HollisterStier announced a $92 million expansion plan to its existing manufacturing lines, which will allow the company to increase capacity by 50%. The

Eliem Therapeutics raised $60 million in a Series B funding round to advance its pipeline of clinical and preclinical drugs, following closely on the heel

Seattle has long been known as a tech hub – but now, it’s poised for a life science boom. With lab space increasingly hard to

Following a banner year for Sana Biotechnology, which saw the company bring in one of the largest IPOs in biotech history, CEO Steve Harr is

Creative Destruction Lab, a nonprofit that runs nine startup accelerators across the world, is opening a new outpost in Seattle. The 9-month program, set to

Bristol Myers Squibb reported promising news on its experimental cancer immunotherapy relatlimab after late-stage clinical data showed that when combined with the company’s blockbuster drug

HDT Bio, a Seattle-based biotech company, is taking steps to address rising COVID-19 cases in India by introducing a new vaccine candidate that works similar